Nomura Analyst Sees Good Growth Prospects for Suzuken

Nomura analyst Kyoichiro Shigemura cites expected stable margins and more exclusive specialty-pharmaceutical distribution contracts in Suzuken's prescription-pharmaceutical wholesaling operations.